NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.
Psychedelics
BetterLife Pharma forms psychedelic research advisory board and taps industry veteran Hattie Wells as its first member
BetterLife Pharma Inc tapped the experience of psychedelic pioneer Hattie Wells to join its new psychedelic research advisory board.
Mind Cure Tackles Mental Health Crisis On Two Fronts
Psychedelic Stock Watch connects the dots regarding Mind Cure's clinic launch and latest product development news.
Mind Cure Announces Build-Out of Digital Therapeutics,iSTRYM: A Technology Platform for Mental Wellness Optimization & PsychedelicResearch
Mind Cure's iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.
Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products
Numinus announces a product development agreement with Optimi Health Corp.
CYBIN Provides Update on Patent Filings & Development of Therapeutics Program
Cybin Corp updates investors on its IP development
North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027
PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales.
From USciences to Argentina and beyond, the son of filmmaker Errol Morris explores psychedelics for VICE TV
While the world waited breathlessly this fall for anything resembling definitive results from the Nov. 3 presidential election, one early winner seemed clear: drugs.
New Psychedelics ETF Is Another Sector Milestone
The new Horizons Psychedelic Stock Index ETF will add new demand and increased visibility for psychedelic drug stocks.
Oregon Voters Said Yes To Using Psilocybin As A Mental Health Therapy. What’s Next?
During the November election, Oregon voters approved a measure allowing licensed centers to provide psilocybin, the substance found in “magic mushrooms,” to help treat people experiencing a range of mental health issues.
Minerco Inc The Magic Mushroom Company Signs LOI with Jamaican Firm Lazurus Holistic to Grow, Process and Extract Psilocybin and Cannabis for Export to Canada and Europe
Oakland, California--(Newsfile Corp. - January 4, 2021) - OTC:MINE signs a Joint Venture letter of intent with Lazurus Holistic to serve as psilocybin experts to grow and develop a unique strain of mushrooms specific to Jamaica.
Four Top Psychedelic Stock Picks for 2021
ATLANTA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- 2020 was a banner year for investors in psychedelic companies as investors in Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), 20/20 Global, Inc. (OTC: TWGL), Compass Pathways (NASDAQ: CMPS), and Numinus Wellness Inc. (OTC: LKYSF) saw their money triple and even quadruple.
Might a safer version of a psychedelic help treat depression?
Research in animals suggests that the new compound is neither toxic nor hallucinogenic and that it may help treat a range of psychiatric disorders, including depression and addiction, and possibly anxiety and post-traumatic stress disorder (PTSD).
Best Music Playlists For Psychedelic Therapy Are Explored In New Johns Hopkins Study
Psychedelic therapy sessions often incorporate music—and typically that music is of the classical genre.
Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is announcing a business arrangement with, and a strategic investment in, Heading Health, LLC ("Heading Health"), a psychiatric clinic platform focused on the administration of psychedelic-assisted therapy to treat mental health disorders.